Logo
x

Search

Subscribe Now

Multiple Chronic Inflammatory Conditions

Fresenius Kabi Launches Idacio (biosimilar- adalimumab) for Multiple Chronic Inflammatory Conditions in Canada

Fresenius Kabi Launches Idacio (biosimilar- adalimumab) for Multiple Chronic Inflammatory Conditions in Canada

  • February 19, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.